Pro-Pharma Care Private Limited - Due diligence report

A 360° intelligence report on Pro-Pharma Care: trust score, financial health, credit view, compliance, directors, growth and distress signal…

2012-11-07 Roorkee, Uttarakhand Active Unlisted Active Compliant
Share
PC Pro-Pharma Care Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Pro-Pharma Care — 360° Intelligence Report

Generated from MCA filings & public records
81/100
Trust Score
Low Risk

Pro-Pharma Care is assessed as Low Risk with a Trust Score of 81/100. Pro-Pharma Care is an active private limited indian non-government company incorporated in 2012, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.

Report generated on 18 Jul 2026 from the latest processed filings. Pro-Pharma Care Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
81/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
73/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
80/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
80/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
60/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 80/100 Low Risk
  • Moderate gearing (D/E 38%).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 1 open (7.75 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Axis Bank Limited1 48.0 cr
Compliance Score: 73/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • Litigation present in 1 court forum(s).
  • Delayed payments to MSME suppliers disclosed (8 disclosure(s)).
  • 1 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
YOGESH VERMA 01234567 Director 01/04/2018 6 yrs Approved
SUBHASH RIJHWANI 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • 3 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2024 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Pro Laboratories Private Limited
Subsidiaries
-
Group entities
-
Capital events
3 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Pro Laboratories Private Limited Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 60 · Distress 75
Growth signals & trust indicators
Steady revenue growth: +1.42 over 4 year(s).
Operating for 13+ years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
1 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 6.77 Lakh.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence76/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment78/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 7.75 cr already registered.
  • Compliance record supports lending.
Investor view72/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 14 events
28 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
25 Oct 2023
Director ceased
HARSH SANGHVI
Director ceased
AJAY CHORDIA
Director ceased
PANKAJ BADLANI
30 Sep 2017
Director ceased
YOGESH VERMA
31 May 2017
Director appointed
YOGESH VERMA (Director)
15 Oct 2016
Securities allotted
1500000 Equity Shares - 2.00 cr raised
08 Feb 2014
Securities allotted
2065000.00 Equity Shares - 2.07 cr raised
11 Jan 2014
Charge created
Axis Bank Limited - 7.75 cr
17 Dec 2013
Director ceased
BRAJESH KASTURI
30 Mar 2013
Securities allotted
70000.00 Equity Shares - 7.00 Lakh raised
07 Nov 2012
Incorporated
Registered with Roc Uttarakhand
Director appointed
SUBHASH RIJHWANI (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - manageable leverage.
Net worth is positive.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 3 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Vijaya Sai Laboratories India Private Limited U24100TG2010PTC069188 Bhiknur Mandal, Telangana, India
Aavishkar U24100TG2013PTC089852 Kothur, Telangana, India
Ark Golden U24229GJ2003PTC071068 Vadodara, Gujarat, India
Ultra Laboratories Private Limited U24231KA2006PTC038442 Bangalore, Karnataka, India
Giyaanpharma U24100TG1992PTC015124 Serilingampally, Telangana, India
Swiss Pharma U24231GJ1987PTC009343 Ahmedabad, Gujarat, India
Acechemie Zynk Energy Limited U24232GJ2015PLC085471 Amod, Gujarat, India
Mmc Health Care Limited U93090TN1996PLC034651 Chennai, Tamil Nadu, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Pro-Pharma Care before audits and certifications: compliance score 73/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Pro-Pharma Care: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 80/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 60/100, margin trends, ownership structure and peer set for Pro-Pharma Care - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 81/100, distress signals and MSME payment-delay disclosures - know whether Pro-Pharma Care pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Pro-Pharma Care - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Pro-Pharma Care an active company?

Pro-Pharma Care has MCA status “Active” with a compliance score of 73/100 (Moderate).

Is Pro-Pharma Care financially healthy?

Pro-Pharma Care has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.

Should I do business with Pro-Pharma Care?

Its overall Trust Score is 81/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Pro-Pharma Care?

The ultimate holding entity is Pro Laboratories Private Limited. 2 active director(s) are on record.

Does Pro-Pharma Care have loans or charges against its assets?

1 open charge(s) are registered against its assets.

Is Pro-Pharma Care up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 73/100 (Moderate).

Is it risky to lend to Pro-Pharma Care?

Its Credit Risk Score is 80/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.